Cargando…
Gene clusters based on OLIG2 and CD276 could distinguish molecular profiling in glioblastoma
BACKGROUND: The molecular profiling of glioblastoma (GBM) based on transcriptomic analysis could provide precise treatment and prognosis. However, current subtyping (classic, mesenchymal, neural, proneural) is time-consuming and cost-intensive hindering its clinical application. A simple and efficie...
Autores principales: | Fu, Minjie, Zhang, Jinsen, Li, Weifeng, He, Shan, Zhang, Jingwen, Tennant, Daniel, Hua, Wei, Mao, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474912/ https://www.ncbi.nlm.nih.gov/pubmed/34565408 http://dx.doi.org/10.1186/s12967-021-03083-y |
Ejemplares similares
-
OLIG2 expression level could be used as an independent prognostic factor for patients with cerebellar Glioblastoma (cGBM)
por: Zhou, Jia, et al.
Publicado: (2023) -
Profiling Glioblastoma Cases with an Expression of DCX, OLIG2 and NES
por: Odrzywolski, Adrian, et al.
Publicado: (2021) -
Use of Bevacizumab in recurrent glioblastoma: a scoping review and evidence map
por: Fu, Minjie, et al.
Publicado: (2023) -
Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2
por: Bouchart, Christelle, et al.
Publicado: (2019) -
Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome
por: Chakrabarti, Lina, et al.
Publicado: (2010)